Sep 2026· Trends in Genetics· 0 citations· 156 references
Medicine
TL;DR
How advances in large DNA assembly, synthetic biology, and genome-wide validation are making chromosome-scale genome engineering an increasingly tractable experimental framework for understanding, building, and repairing genomes is discussed, while outlining the analytical requirements and current technical barriers that limit routine implementation.
Abstract
Genome engineering is moving from local sequence modification to manipulation of megabase-scale regions and whole chromosomes. This shift reflects the growing recognition that many biological functions and disease states are shaped by chromosome-scale features, including gene dosage across multiple loci, long-range regulation, chromatin context, replication timing, competition for limiting epigenetic factors, and three-dimensional genome organization. Here, we review the toolkit for chromosome-scale manipulation in higher eukaryotes, focusing on chromosome transfer, targeted chromosome elimination, and their integration into chromosome transplantation workflows. We discuss how these approaches, together with advances in large DNA assembly, synthetic biology, and genome-wide validation, are making chromosome-scale genome engineering an increasingly tractable experimental framework for understanding, building, and repairing genomes, while outlining the analytical requirements and current technical barriers that limit routine implementation.
This review dissects the technological foundations and limiting factors of multiplex genome editing, focusing on guide RNA (gRNA) array engineering, delivery constraints, and scale‐dependent safety risks.
Lin-Li Wang, Yong-Bin Liu, Hong-Bing Han· Animal Research and One Heal...· 0 citations
ABSTRACT Advances in long‐read sequencing and Hi–C scaffolding have made chromosome‐level genome assembly increasingly accessible to individual laboratories, shifting genome research from large consortium‐led projects toward investigator‐driven studies across diverse taxa. This transition allows researchers to select o...
Tetsuo Kon, Kosuke Kataoka, Yi-Jyun Luo et al.· Genes to Cells· 0 citations
Recent advances in programmable large-DNA writing in the human genome are reviewed across four mechanistic categories: recombinase-, prime editing-, transposase-, and retrotransposon-mediated technologies.
Joon A. Shin, Matthew Hoffman, Xin D. Gao· Current Opinion in Chemical...· 0 citations
Human artificial chromosomes (HACs) are engineered, chromosome-scale DNA molecules that replicate and segregate autonomously in mammalian cells, offering a unique platform for large, stable, nonintegrating genetic delivery. The first generation of HACs emerged prior to synthetic genomics efforts, and their development...
Alexandra Dananberg, Gabriel J. Birchak, Ben E. Black· Annual Review of Genetics· 0 citations
Current CRISPR/dCas-based approaches for engineering three-dimensional genome architecture are summarized, their mechanistic basis and applications are discussed, and emerging therapeutic opportunities and major technical challenges in the field are highlighted.
N. Mamaeva, Valeriy A. Yakovlev, Nikolay V. Kristovskiy et al.· International Journal of Mol...· 0 citations
Exploring how generative AI could make machine vision more accessible to businesses. The post GenEye in a Box: Making Machine Vision Something You Can Just Ask For appeared first on GPT-Lab.